Influenza is a severe public health problem due to the high number of hospitalizations and deaths. Most influenza-associated deaths occur among people aged 65 and older. Although the disease can be prevented with vaccination, prevention programs are below the desirable threshold due to vaccine hesitancy and no-vax theory. Additionally, the antigenic variations of influenza viruses pose a significant obstacle for the immunization of the population, reducing confidence in vaccination practices [11].